1-3 of 3
Brian D. Thrall
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Microdistribution and Long-term Retention of 239Pu (NO3)4 in the Respiratory Tracts of an Acutely Exposed Plutonium Worker and Experimental Beagle Dogs

Christopher E. Nielsen, Dulaney A. Wilson, Antone L. Brooks, Stacey L. McCord, Gerald E. Dagle, Anthony C. James, Sergei Y. Tolmachev, Brian D. Thrall, William F. Morgan
Journal: Cancer Research
Cancer Res (2012) 72 (21): 5529–5536.
https://doi.org/10.1158/0008-5472.CAN-12-1824
Published: 31 October 2012
View article titled, Microdistribution and Long-term Retention of <sup>239</sup>Pu (NO<sub>3</sub>)<sub>4</sub> in the Respiratory Tracts of an Acutely Exposed Plutonium Worker and Experimental Beagle Dogs
Open the PDF for Microdistribution and Long-term Retention of <sup>239</sup>Pu (NO<sub>3</sub>)<sub>4</sub> in the Respiratory Tracts of an Acutely Exposed Plutonium Worker and Experimental Beagle Dogs in another window
Journal Articles

In Vivo Transfection of Melanoma Cells by Lithotripter Shock Waves

Shiping Bao, Brian D. Thrall, Richard A. Gies, Douglas L. Miller
Journal: Cancer Research
Cancer Res (1998) 58 (2): 219–221.
Published: 01 January 1998
View article titled, <em>In Vivo</em> Transfection of Melanoma Cells by Lithotripter Shock Waves
Open the PDF for <em>In Vivo</em> Transfection of Melanoma Cells by Lithotripter Shock Waves in another window
Journal Articles

Methylazoxyprocarbazine, the Active Metabolite Responsible for the Anticancer Activity of Procarbazine against L1210 Leukemia

Diane Shomin Swaffar, Michael G. Horstman, John-Yan Jaw, Brian D. Thrall, Gary G. Meadows, W. Graydon Harker, Garold S. Yost
Journal: Cancer Research
Cancer Res (1989) 49 (9): 2442–2447.
Published: 01 May 1989
View article titled, Methylazoxyprocarbazine, the Active Metabolite Responsible for the Anticancer Activity of Procarbazine against L1210 Leukemia
Open the PDF for Methylazoxyprocarbazine, the Active Metabolite Responsible for the Anticancer Activity of Procarbazine against L1210 Leukemia in another window